(Q38540262)

3 September 2017

1 reference

title

The role of regulatory T cells and microglia in glioblastoma-associated immunosuppression (English)

1 reference

3 September 2017

0 references

1 reference

Alfred P See

1

1 reference

3 September 2017

Jonathon J Parker

series ordinal

2

1 reference

3 September 2017

Allen Waziri

series ordinal

3

1 reference

3 September 2017

language of work or name

1 reference

30 June 2015

1 reference

Journal of Neuro-Oncology

3 September 2017

published in

1 reference

3 September 2017

volume

123

1 reference

3 September 2017

issue

3

1 reference

3 September 2017

page(s)

405-412

1 reference

Regulatory T cells in cancer

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1849-3

Engagement of B7 on effector T cells by regulatory T cells prevents autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1849-3

What are regulatory T cells (Treg) regulating in cancer and why?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1849-3

The regulatory T cell-associated transcription factor FoxP3 is expressed by tumor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1849-3

Control of regulatory T cell development by the transcription factor Foxp3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1849-3

Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1849-3

Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1849-3

Induced and natural regulatory T cells in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1849-3

Mechanisms of suppression by suppressor T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1849-3

Human T regulatory cells can use the perforin pathway to cause autologous target cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1849-3

IDO expression in brain tumors increases the recruitment of regulatory T cells and negatively impacts survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1849-3

Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1849-3

Thymus-derived rather than tumor-induced regulatory T cells predominate in brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1849-3

The multifaceted role of Th17 lymphocytes and their associated cytokines in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1849-3

The Treg/Th17 paradigm in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1849-3

Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1849-3

TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1849-3

Molecular antagonism and plasticity of regulatory and inflammatory T cell programs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1849-3

Increased regulatory T-cell fraction amidst a diminished CD4 compartment explains cellular immune defects in patients with malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1849-3

An increase in CD4+CD25+FOXP3+ regulatory T cells in tumor-infiltrating lymphocytes of human glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1849-3

Preferential in situ CD4+CD56+ T cell activation and expansion within human glioblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1849-3

Effector T-cell infiltration positively impacts survival of glioblastoma patients and is impaired by tumor-derived TGF-β.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1849-3

Incidence and prognostic impact of FoxP3+ regulatory T cells in human gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1849-3

CD4+ CD25+ FoxP3+ T-cell infiltration and heme oxygenase-1 expression correlate with tumor grade in human gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1849-3

Prognostic significance and mechanism of Treg infiltration in human brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1849-3

Immune modulation effects of concomitant temozolomide and radiation therapy on peripheral blood mononuclear cells in patients with glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1849-3

Greater chemotherapy-induced lymphopenia enhances tumor-specific immune responses that eliminate EGFRvIII-expressing tumor cells in patients with glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1849-3

Anti-PD-1 blockade and stereotactic radiation produce long-term survival in mice with intracranial gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1849-3

Treg depletion inhibits efficacy of cancer immunotherapy: implications for clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1849-3

CD25 blockade depletes and selectively reprograms regulatory T cells in concert with immunotherapy in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1849-3

A pilot study of IL-2Rα blockade during lymphopenia depletes regulatory T-cells and correlates with enhanced immunity in patients with glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1849-3

Denileukin diftitox: a biotherapeutic paradigm shift in the treatment of lymphoid-derived disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1849-3

Durable therapeutic efficacy utilizing combinatorial blockade against IDO, CTLA-4, and PD-L1 in mice with brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1849-3

Reversal of myeloid cell-mediated immunosuppression in patients with metastatic renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1849-3

All-trans-retinoic acid improves differentiation of myeloid cells and immune response in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1849-3

Tumor associated macrophages and neutrophils in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1849-3

Myeloid-derived suppressor cell heterogeneity and subset definition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1849-3

Neutrophil degranulation and immunosuppression in patients with GBM: restoration of cellular immune function by targeting arginase I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1849-3

Systemic immune suppression in glioblastoma: the interplay between CD14+HLA-DRlo/neg monocytes, tumor factors, and dexamethasone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1849-3

Myeloid-derived suppressor cell accumulation and function in patients with newly diagnosed glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1849-3

Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1849-3

Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1849-3

ATP mediates rapid microglial response to local brain injury in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1849-3

Confocal imaging of microglial cell dynamics in hippocampal slice cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1849-3

Purines induce directed migration and rapid homing of microglia to injured pyramidal neurons in developing hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1849-3

Origin and differentiation of microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1849-3

The multifaceted profile of activated microglia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1849-3

Microglia in brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1849-3

Gefitinib selectively inhibits tumor cell migration in EGFR-amplified human glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1849-3

Human leukocyte antigen and antigen processing machinery component defects in astrocytic tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1849-3

Astrocytic regulation of human monocytic/microglial activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1849-3

Expression of Fas ligand by microglia: possible role in glioma immune evasion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1849-3

Normal human monocytes exposed to glioma cells acquire myeloid-derived suppressor cell-like properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1849-3

Role of Stat3 in suppressing anti-tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1849-3

The incidence, correlation with tumor-infiltrating inflammation, and prognosis of phosphorylated STAT3 expression in human gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1849-3

Glioma cancer stem cells induce immunosuppressive macrophages/microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1849-3

Stat3 inhibition activates tumor macrophages and abrogates glioma growth in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1849-3

Glioblastoma cancer-initiating cells inhibit T-cell proliferation and effector responses by the signal transducers and activators of transcription 3 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1849-3

miR-124 inhibits STAT3 signaling to enhance T cell-mediated immune clearance of glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1849-3

Carbon nanotubes enhance CpG uptake and potentiate antiglioma immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1849-3

Immunology in the clinic review series; focus on cancer: tumour-associated macrophages: undisputed stars of the inflammatory tumour microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1849-3

Microglia regulate the number of neural precursor cells in the developing cerebral cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1849-3

Dendritic Cell Vaccination in Combination with Anti-CD25 Monoclonal Antibody Treatment: A Phase I/II Study in Metastatic Melanoma Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1849-3

IL-10 Is Required for Regulatory T Cells to Mediate Tolerance to Alloantigens In Vivo

21 January 2018

1 reference

12 December 2020

Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

1 reference

12 December 2020

Molecular mechanisms that influence the macrophage m1-m2 polarization balance

1 reference

12 December 2020

Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer

1 reference

12 December 2020

Myeloid-derived suppressor cells in inflammation: uncovering cell subsets with enhanced immunosuppressive functions

1 reference

12 December 2020

Expanded subpopulation of FoxP3+ T regulatory cells in renal cell carcinoma co-express Helios, indicating they could be derived from natural but not induced Tregs

1 reference

12 December 2020

Immature immunosuppressive CD14+HLA-DR-/low cells in melanoma patients are Stat3hi and overexpress CD80, CD83, and DC-sign

1 reference

12 December 2020

Functional maturation of adult mouse resting microglia into an APC is promoted by granulocyte-macrophage colony-stimulating factor and interaction with Th1 cells

1 reference

12 December 2020

Microglia and macrophages in malignant gliomas: recent discoveries and implications for promising therapies

1 reference

12 December 2020

10.1007/S11060-015-1849-3

Identifiers

DOI

1 reference

Dimensions Publication ID

3 September 2017

1028325349

0 references

1 reference